OXYGENTA PHARMACEUTICAL
Smallcap | BSE
Sector
Here's the live share price of Oxygenta Pharmaceutical along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-4.05₹ -2.34
As on May 15, 2026, 04:01 PM IST
Oxygenta Pharmaceutical Price Performance
Today's LowToday's High
₹55.40₹57.44
₹55.50
52 Weeks' Low52 Weeks' High
₹45.30₹133.50
₹55.50
Open Price
₹56.25
Prev. Close
₹57.84
Volume
6,376
Oxygenta Pharmaceutical Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Oxygenta Pharmaceutical | -1 | -2 | 5.23 | -10.94 | -37 | 23.1 | 42.13 |
| Sun Pharmaceutical Industries | 1.76 | 11.03 | 10.6 | 6.59 | 8.35 | 25.42 | 22.3 |
| Divi's Laboratories | 0.69 | 7.26 | 9.77 | 3.55 | 7.54 | 27.27 | 10.81 |
| Torrent Pharmaceuticals | 0.13 | 5.53 | 2.95 | 14.91 | 34.35 | 38.04 | 25.98 |
| Cipla | 6.22 | 16.32 | 5.59 | -6.82 | -4.54 | 15.76 | 10.19 |
| Dr. Reddy's Laboratories | 3.38 | 9.47 | 5.33 | 7.43 | 8.65 | 13.95 | 4.95 |
| Lupin | -4.37 | -2.26 | 2.4 | 10.83 | 9.94 | 42.42 | 13.85 |
| Mankind Pharma | 3.29 | 19.11 | 20.41 | 11.68 | -2.39 | 21.87 | 11.98 |
| Zydus Lifesciences | 7.71 | 7.67 | 11.13 | 8.24 | 11.99 | 25 | 10.58 |
| Aurobindo Pharma | 1.52 | 9.02 | 27.53 | 22.14 | 25.74 | 35.05 | 8.56 |
| Laurus Labs | 7.73 | 17.25 | 30.77 | 29.56 | 119.68 | 62.04 | 22.88 |
| Biocon | 13.01 | 22.68 | 13.1 | 2.08 | 26.67 | 20.17 | 2.2 |
| Alkem Laboratories | -1.78 | -1.62 | -0.05 | -4.29 | 4.91 | 17.03 | 12.94 |
| Glenmark Pharmaceuticals | -1.85 | 3.16 | 14.24 | 24.39 | 60.35 | 56.22 | 30.89 |
| Abbott India | 4.87 | 8.11 | 6.22 | -5.55 | -8.51 | 9.63 | 11.5 |
| Anthem Biosciences | -0.33 | 8.21 | 13.6 | 17.51 | 7.07 | 2.3 | 1.38 |
| GlaxoSmithKline Pharmaceuticals | -1.74 | 0.92 | -6.04 | -2 | -13.66 | 24.01 | 9.97 |
| Ipca Laboratories | 4.2 | 10.66 | 7.8 | 10.53 | 16.12 | 32.51 | 8.22 |
| Ajanta Pharma | 4.21 | 11.74 | 7.4 | 26.23 | 21.42 | 35.49 | 19.32 |
| J B Chemicals & Pharmaceuticals | -1.01 | 7.87 | 7.7 | 16.9 | 29.36 | 27.7 | 25.39 |
Over the last one year, Oxygenta Pharmaceutical has declined 37.00% compared to peers like Sun Pharmaceutical Industries (8.35%), Divi's Laboratories (7.54%), Torrent Pharmaceuticals (34.35%). From a 5 year perspective, Oxygenta Pharmaceutical has outperformed peers relative to Sun Pharmaceutical Industries (22.30%) and Divi's Laboratories (10.81%).
Oxygenta Pharmaceutical Financials
Oxygenta Pharmaceutical Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 56.21 | 55.4 |
| 10 | 55.99 | 55.62 |
| 20 | 56 | 55.19 |
| 50 | 52.43 | 54.29 |
| 100 | 54.29 | 56.23 |
| 200 | 64.18 | 62.03 |
Oxygenta Pharmaceutical Share Holding Pattern
In the latest quarter, Oxygenta Pharmaceutical saw a rise in promoter holding to 56.53%, while DII stake unchanged at 0.03%, FII holding unchanged at 0.00%, and public shareholding moved down to 43.44% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Oxygenta Pharmaceutical Corporate Actions
Date Time | Announcement |
|---|---|
| Apr 27, 2026, 09:10 PM IST IST | Oxygenta Pharma. - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 |
| Apr 27, 2026, 09:03 PM IST IST | Oxygenta Pharma. - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A |
| Apr 15, 2026, 05:47 AM IST IST | Oxygenta Pharma. - Compliance As Per Regulation 74(5) Of SEBI (Depositories And Participants) Regulations, 2018 For The Quart |
| Feb 20, 2026, 10:07 PM IST IST | Oxygenta Pharma. - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2 |
| Feb 04, 2026, 11:40 PM IST IST | Oxygenta Pharma. - Un-Audited Results For The Quarter And Nine Months Ended 31.12.2025. |
About Oxygenta Pharmaceutical
Oxygenta Pharmaceutical Ltd. is a Public Limited Listed company incorporated on 27/11/1990 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24110TG1990PLC012038 and registration number is 012038. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 109.30 Cr. and Equity Capital is Rs. 36.98 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressSurvey. No. 252/1, Sangareddy Dist. Telangana 502291
- Contact
Management
- Mr. Balasubba Reddy MamillaExecutive Director
- Mr. Chandra Mouliswar Reddy GangavaramExecutive Director
- Mrs. Vedavathi GangavaramNon Exe.Non Ind.Director
- Mr. Sidda Reddy KanuparthiInd. Non-Executive Director
- Mr. Veera Reddy AravaInd. Non-Executive Director
- Mrs. Sharvari Swapnil ShindeInd. Non-Executive Director
FAQs on Oxygenta Pharmaceutical Share Price
What is the share price of Oxygenta Pharmaceutical?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Oxygenta Pharmaceutical is ₹55.50 as on May 15, 2026.
What kind of stock is Oxygenta Pharmaceutical?
The Oxygenta Pharmaceutical is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Oxygenta Pharmaceutical?
The market cap of Oxygenta Pharmaceutical is ₹205.26 Cr as on May 15, 2026.
What are today's High and Low prices of Oxygenta Pharmaceutical?
Today’s highest and lowest price of Oxygenta Pharmaceutical are ₹57.44 and ₹55.40.
What are the 52 Week High and 52 Week Low of Oxygenta Pharmaceutical?
The 52-week high/low is the highest and lowest price at which Oxygenta Pharmaceutical stock has traded in the past 52-week or nearly a year. The 52-week high of Oxygenta Pharmaceutical is ₹133.50 and 52-week low of Oxygenta Pharmaceutical is ₹45.30 as on May 15, 2026.
How has the Oxygenta Pharmaceutical performed historically in terms of returns?
The Oxygenta Pharmaceutical has shown returns of -4.05% over the past day, 0.6% for the past month, 5.23% over 3 months, -37.64% over 1 year, 23.1% across 3 years, and 42.13% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Oxygenta Pharmaceutical?
P/E ratio of and PB ratio of Oxygenta Pharmaceutical are -11.38 and -4.94 on May 15, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse